Clinical Trial Update: To Evaluate the Efficacy of Adebrelimab Combined With Chemotherapy After HIFU Induction Neoadjuvant Therapy HR+/HER2- Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Adebrelimab in combination with chemotherapy after HIFU-based neoadjuvant therapy for hormone receptor-positive, HER2-negative…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Breast Cancer, HR+/HER2- Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING